Page URL: https://www.bionews.org.uk/page_89337

Gene clue to mood disorders

9 July 2004
By BioNews
Appeared in BioNews 266

US researchers have identified a genetic variation in mice that affects levels of the 'feel-good' brain chemical serotonin. The study, published in the journal Science, could shed light on why some people are prone to depression and other mood disorders. The findings could also help explain why some patients respond well to anti-depressants such as Prozac, which aim to boost brain serotonin levels, while others do not.

Serotonin is a neurotransmitter, a chemical that enables brain cells to communicate with each other. Scientists have long known that levels of serotonin are linked to feelings of emotional well-being - a study published last year showed that a gene involved in serotonin production appears to affect a person's ability to cope with stressful life events. However, the latest study is the first to identify a genetic difference that directly affects levels of serotonin in the brain.

The researchers, based at Duke University Medical School, looked at two different versions of a mouse gene called Tph2. They found that one version was linked to a reduction in the level of brain serotonin of between 50 to 70 per cent. The findings suggest that 'there really are heritable differences in how the brain makes or synthesises serotonin', commented Jerrold Rosenbaum, chief of psychiatry at Massachusetts General Hospital in Boston. 'It gives us a whole new line of inquiry, both as to tailored treatment and to understanding how treatments work, and why there are differences in response', he added.

Patients with depression are often prescribed drugs that boost serotonin levels, called selective serotonin reuptake inhibitors (SSRIs), of which Prozac is one. But according to Rosenbaum, 'only 30 to 40 per cent of people given an SSRI really get a high quality response' from the drug. The Duke scientists are now looking for similar genetic differences in humans;  research that could eventually lead to 'psychiatric pharmacogenetics', says team leader Marc Caron. By identifying these differences, 'doctors will be able to predict in advance who'll respond to a serotonin-augmenting drug and who is less likely to do so, so you could spare the person ineffective trials or side effects', he said.

SOURCES & REFERENCES
Gene Controls Serotonin, a Key to Good Moods
Genome News Network |  8 July 2004
Gene Discovery Could Change Psychiatric Care
Forbes.com |  8 July 2004
Gene fault linked to depression
BBC News Online |  8 July 2004
Happiness may be all in the genes
The Guardian |  9 July 2004
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
16 September 2013 - by Simon Hazelwood-Smith 
The eating disorder anorexia nervosa has been linked, somewhat unexpectedly, to variants in a gene involved in cholesterol regulation...
4 July 2011 - by Ruth Pidsley 
Scientists have shown that the effects of stress can be passed from one generation to the next via chemical changes to the DNA which turn genes on or off without altering the code itself....
23 May 2011 - by Dr Rosie Morley 
Scientists believe they have identified a new genetic link to severe depression....
10 March 2008 - by Dr Rebecca Robey 
British and Australian scientists have found that a person's genes can predispose them towards happiness. Reporting in the journal Psychological Science, the researchers found that genes account for 50 per cent of the factors contributing to an individual's satisfaction with life, with external influences such as health...
11 May 2005 - by BioNews 
A gene variation previously linked to depression and anxiety affects brain regions involved in processing fear and 'dampening' negative emotions, US scientists say. The short version of the serotonin transporter (5-HTT) gene is linked to an increased risk of depression following stress. Researchers at the National Institute of Mental...
21 July 2003 - by BioNews 
How well people cope with stressful experiences such as divorce or unemployment is partly down to variations in a single gene, according to a new study by researchers based in the UK, US and New Zealand. The scientists, who published their findings in last week's Science, found that different versions...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.